Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Frey

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
The AAPS Journal|March 31, 2018
Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect ModelsSimon Buatois, Sebastian Ueckert, Nicolas Frey, et al.
Studies in Health Technology and Informatics|May 23, 2026
Physicians' Perspectives on Predictive Uncertainty in Machine Learning ModelsNicolas Frey, Niklas Giesa, Louis Agha-Mir-Salim, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 10, 2021
Population pharmacokinetic and exposure-response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemiaEkaterina Gibiansky, Leonid Gibiansky, Clarisse Chavanne, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2018
Pediatric Dosing of Ganciclovir and Valganciclovir: How Model-Based Simulations Can Prevent Underexposure and Potential Treatment FailureKarin Jorga, Bruno Reigner, Clarisse Chavanne, et al.
Clinical Pharmacokinetics|June 7, 2020
Population Pharmacokinetic Analysis and Exploratory Exposure-Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia ASylvie Retout, Christophe Schmitt, Claire Petry, et al.
Studies in Health Technology and Informatics|May 17, 2025
Clinical Requirements for Transparent Machine Learning Model Information: A Mixed Methods Study ProtocolLouis Agha-Mir-Salim, Nicolas Frey, Lina Mosch, et al.
Statistics in Medicine|March 2, 2021
cLRT-Mod: An efficient methodology for pharmacometric model-based analysis of longitudinal phase II dose finding studies under model uncertaintySimon Buatois, Sebastian Ueckert, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 22, 2014
Methods to detect non-compliance and reduce its impact on population PK parameter estimatesLeonid Gibiansky, Ekaterina Gibiansky, Valerie Cosson, et al.
Basic & Clinical Pharmacology & Toxicology|January 7, 2010
An integrated model for the glucose-insulin systemHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 8, 2006
Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysisAnnabelle Lemenuel-Diot, Christian Laveille, Nicolas Frey, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
The AAPS Journal|March 31, 2018
Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect ModelsSimon Buatois, Sebastian Ueckert, Nicolas Frey, et al.
Studies in Health Technology and Informatics|May 23, 2026
Physicians' Perspectives on Predictive Uncertainty in Machine Learning ModelsNicolas Frey, Niklas Giesa, Louis Agha-Mir-Salim, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 10, 2021
Population pharmacokinetic and exposure-response analyses of intravenous and subcutaneous rituximab in patients with chronic lymphocytic leukemiaEkaterina Gibiansky, Leonid Gibiansky, Clarisse Chavanne, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2018
Pediatric Dosing of Ganciclovir and Valganciclovir: How Model-Based Simulations Can Prevent Underexposure and Potential Treatment FailureKarin Jorga, Bruno Reigner, Clarisse Chavanne, et al.
Clinical Pharmacokinetics|June 7, 2020
Population Pharmacokinetic Analysis and Exploratory Exposure-Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia ASylvie Retout, Christophe Schmitt, Claire Petry, et al.
Studies in Health Technology and Informatics|May 17, 2025
Clinical Requirements for Transparent Machine Learning Model Information: A Mixed Methods Study ProtocolLouis Agha-Mir-Salim, Nicolas Frey, Lina Mosch, et al.
Statistics in Medicine|March 2, 2021
cLRT-Mod: An efficient methodology for pharmacometric model-based analysis of longitudinal phase II dose finding studies under model uncertaintySimon Buatois, Sebastian Ueckert, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 22, 2014
Methods to detect non-compliance and reduce its impact on population PK parameter estimatesLeonid Gibiansky, Ekaterina Gibiansky, Valerie Cosson, et al.
Basic & Clinical Pharmacology & Toxicology|January 7, 2010
An integrated model for the glucose-insulin systemHanna E Silber, Petra M Jauslin, Nicolas Frey, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 8, 2006
Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysisAnnabelle Lemenuel-Diot, Christian Laveille, Nicolas Frey, et al.
Pageof 6